Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of Veterinary Internal Medicine
|
December 10, 1999
Treatment of canine mast cell tumors with CCNU (lomustine)
K M Rassnick, A S Moore, L E Williams, et al.
Journal of Veterinary Internal Medicine
|
September 28, 1999
Lomustine (CCNU) for the treatment of resistant lymphoma in dogs
A S Moore, C A London, C A Wood, et al.
Experimental Hematology
|
June 1, 1996
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma
D M Vail, W C Kisseberth, J E Obradovich, et al.
Journal of Veterinary Internal Medicine
|
July 27, 2001
Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma
A S Moore, S M Cotter, W M Rand, et al.
Veterinary and Comparative Oncology
|
May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma
R Mani, R Yan, X Mo, et al.
Journal of Veterinary Internal Medicine
|
December 2, 2017
c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
K M Weishaar, E J Ehrhart, A C Avery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial
D M Vail, E G MacEwen, I D Kurzman, et al.
Veterinary and Comparative Oncology
|
May 9, 2013
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma
C K Martin, W P Dirksen, M M Carlton, et al.
Journal of the American Veterinary Medical Association
|
May 1, 1996
Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992)
C A London, R R Dubilzeig, D M Vail, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of Veterinary Internal Medicine
|
December 10, 1999
Treatment of canine mast cell tumors with CCNU (lomustine)
K M Rassnick, A S Moore, L E Williams, et al.
Journal of Veterinary Internal Medicine
|
September 28, 1999
Lomustine (CCNU) for the treatment of resistant lymphoma in dogs
A S Moore, C A London, C A Wood, et al.
Experimental Hematology
|
June 1, 1996
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma
D M Vail, W C Kisseberth, J E Obradovich, et al.
Journal of Veterinary Internal Medicine
|
July 27, 2001
Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma
A S Moore, S M Cotter, W M Rand, et al.
Veterinary and Comparative Oncology
|
May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma
R Mani, R Yan, X Mo, et al.
Journal of Veterinary Internal Medicine
|
December 2, 2017
c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
K M Weishaar, E J Ehrhart, A C Avery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial
D M Vail, E G MacEwen, I D Kurzman, et al.
Veterinary and Comparative Oncology
|
May 9, 2013
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma
C K Martin, W P Dirksen, M M Carlton, et al.
Journal of the American Veterinary Medical Association
|
May 1, 1996
Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992)
C A London, R R Dubilzeig, D M Vail, et al.
Page
of 3